about
sameAs
Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical CancerAdvanced Cervical Cancer Trial in IndiaStudy of the Therapeutic Vaccine (ISA101/ISA101b) to Treat Advanced or Recurrent Cervical CancerTrial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal CancerVaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial NeoplasiaAssessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapyPilot Study of Durvalumab and Vigil in Advanced Women's CancersDurvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerMetronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursSGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial NeoplasiaComparison of the Human Papillomavirus (HPV) Type 16 E7-Specific Immune Response Between a Normal Population and Patients With Cervical LesionsThe Development of Human Papillomavirus Type 16 E7-Specific Human Immunologic Assays in Non-HLA2 Type Human BeingCombination of Cryosurgey and NK Immunotherapy for Recurrent Cervical CancerIntervention of CAR-T Against Cervical CancerEngineered Immune Effectors Against Cervical CancerImmunotherapy of Cervical Cancer With V3-CervixAtezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical CancerImmunotherapy of Recurrent Cervical Cancers Using Dendritic Cells (DCs)Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical CancerCAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic CancerImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated CancersT Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 PositiveT Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 PositiveT Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
P1050
Biomarkers in cervical cancer screeningPerinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysisEpigenetics of cervical cancer. An overview and therapeutic perspectivesThe Role of Natural Polyphenols in the Prevention and Treatment of Cervical Cancer-An OverviewImmunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational researchImpact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceMolecular mechanisms of cisplatin resistance in cervical cancerPleiotropic Effects of IL-2 on Cancer: Its Role in Cervical CancerCancer stem cells (CSCs), cervical CSCs and targeted therapiesDiagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-AnalysisChlamydia Trachomatis Infection-Associated Risk of Cervical Cancer: A Meta-AnalysisIndividual management of cervical cancer in pregnancy.Clinical significance of human papillomavirus genotypingA promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ----- CTCF transcriptional repressor regulates c-KIT proto-oncogene expressionCarcinome à cellule vitreuse du col de l’utérus: à propos d’un cas et revue de littératureEwing's sarcoma of the cervix, a diagnostic dilemma: a case report and review of the literatureAre the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPVFactors Predictive of Improved Survival in Patients With Brain Metastases From Gynecologic Cancer: A Single Institution Retrospective Study of 47 Cases and Review of the LiteratureDAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-AnalysisHuman papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspectiveCurrent Advances in the Application of Raman Spectroscopy for Molecular Diagnosis of Cervical CancerHuman papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active womenOccupational cancer in Britain. Female cancers: breast, cervix and ovaryAberrant DNA methylation in cervical carcinogenesisModern radiation therapy and potential fertility preservation strategies in patients with cervical cancer undergoing chemoradiationMultistep model of cervical cancer: participation of miRNAs and coding genesCancer diagnostic classifiers based on quantitative DNA methylationX-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysisA new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literatureBarriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesisMaxillofacial metastasis of genitourinary origin. A report of 3 cases and review of the literatureCervical necrosis after chemoradiation for cervical cancer: case series and literature reviewMolecular detection of human papillomavirus from abnormal cervical cytology of women attending a tertiary health facility in Ido-ekiti, southwest NigeriaNatural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literaturePsoas abscess secondary to retroperitoneal distant metastases from squamous cell carcinoma of the cervix with thrombosis of the inferior vena cava and duodenal infiltration treated by Whipple procedure: A case report and review of the literatureThe vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next?Postoperation of cervical cancer with intestine metastasis: a case report and literature reviewClinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi ArabiaAssociations of P16INK4a promoter hypermethylation with squamous intra-epithelial lesion, cervical cancer and their clinicopathological features: a meta-analysisCurrent global status & impact of human papillomavirus vaccination: Implications for India
P921
Q58407025-2E31480B-35CB-4461-BF41-FE4ADF197644Q58407548-B550AC39-FE40-4565-91D6-4306937E114FQ58407610-8C159523-798F-4A6B-9334-D269B8BE9BF4Q58407623-BDA8A448-7CEE-4169-8031-5DAB2A0E47AAQ58407672-453FB8EE-9D69-48FC-98AF-2B0C80283221Q58407693-E00C453E-0802-40AE-8BD2-4BA72835E4AAQ58407695-90962718-6B9D-4AFC-8BC3-66CF88AD0683Q58407702-9D2E156E-48FF-4F99-A433-8C8AEC695A48Q58407722-3B6BCB56-D4F7-47F7-B236-2F3E168A4B0AQ58407796-DFA6A819-FD70-494E-9883-1F658D9DA83FQ58844270-A86937EA-FE3F-49F6-8DC0-875FAA6F7878Q58844304-30968E5D-A873-41FB-AF93-34F5ECF05E24Q58844311-9178BCDA-CE75-40AD-8CF6-66288FCE5A87Q58845767-E831B152-B8BE-4A58-95D8-7EB72BED858DQ58846664-81138833-D9A3-4931-B86E-13A2B5D5AB9FQ58846719-573C21A7-CB09-4729-97EF-43BD62EE724EQ58846920-256E297C-32A2-4B8B-8406-9C4426323EE3Q58847243-7968FCCA-E435-401D-8F8E-E8C08A4D2C4EQ58849045-F319950F-8DD8-4105-8F00-2FEA481E611EQ58849364-10E19771-9F73-4128-921C-59DB4BF674EEQ58849462-3688BA73-9E43-4D83-BFC6-C15D8C3B711BQ58849469-4B5CDED3-77B0-48C4-87E3-9FF8CD743DBDQ58849570-E6AB4FFB-336D-409C-B093-1C258D7B82CFQ58849611-8D91077C-B4C3-4AF6-8FB9-7E1053C90D58Q58849702-E02838B3-CC75-489D-B454-BF092186A277
P1050
Q22306444-C1EF5C01-E37E-49C3-BBA2-5A085BC510A8Q24647649-17C01D5E-45A6-475F-BEB3-C43043050289Q24812104-05A134FB-F40E-4A69-AC79-E3B90141B586Q26739983-024AEE17-BAD5-4A5D-9B9E-5DEF6951FC1DQ26744094-FDE6AF02-2C9B-41CE-BF24-FAA3CCB60BCAQ26745696-753197C7-2967-4D53-80C3-962EB4616717Q26746228-E97B34E1-8642-45E5-8BA0-3A2CAFEE2568Q26747008-FC2FC94B-8C3F-4AB3-94C2-DCDA9E04DEBBQ26747144-36408B35-91B2-4627-B3CB-3F270D73D17FQ26749186-BB8B2155-7534-4137-B435-BF97697522D6Q26752543-37F84B07-E68C-42A2-998C-0FD96AB90C6CQ26771286-527F1C47-FD11-4581-BC2A-26DC42F83D23Q26771981-C21A1F40-84BF-4E5C-9F6A-331897400241Q26775443-5F6A980C-1CB4-45FC-B595-B632509B168CQ26776221-3AC12BE0-D9A3-490B-9B54-769A43EC8FC3Q26778559-C7FC5447-17F9-4769-AF13-049CC3F18AD0Q26783973-B2F90BD1-6873-41A0-A449-88D970BC24E3Q26786526-372643D8-D574-4266-9992-7BDEC07042BCQ26798393-8EE227D5-4D04-4B70-81D1-4E9F58FD2B01Q26799791-752EFA72-B5AA-4AF3-95E9-9201CFE38D5DQ26800277-1C435BAB-C84A-4DEE-B9B6-16A189C2ECCDQ26824062-2EA527EB-5617-4146-A6DC-F6FC32BEBE95Q26828550-91DB2A1D-2CC5-4620-9609-595B86810F4DQ26830289-AC364A6A-9D8C-42F3-90BA-6BEF435FEBDCQ26851577-BF2E6CEF-5DD7-4AD8-9330-2C4EB4DB5F0AQ27001000-425BE530-7D05-49EE-BD16-3AD55BBAC042Q27012960-481482BC-8C65-40C3-8598-18E024E5881CQ27014702-2903D907-A32A-4F3D-B5C2-6BE4E4A99D77Q27022717-F7BE94EF-DE18-4B1D-A755-1FDF57D30228Q27027935-9D1B315F-C039-448F-8E29-C9BC00424DECQ27028031-2413BB7B-5A3D-446B-8991-C7489F3302E2Q27693863-BCB75C60-54E8-48B0-9D57-711BB5F4718FQ28071607-B1D786FE-9E00-4978-8A7B-6B78E086D540Q28072648-910C2F12-9952-4E6D-A414-DD81FDEFDADEQ28073990-C311ED7F-2715-4421-931B-B936C6CE92CCQ28074014-C7CADF29-8A68-4DA7-A203-E0395D9FD25AQ28075510-3465C7C0-26DA-4C9E-A019-9CB7315C1C49Q28076573-60EA61EE-361B-4F9B-B950-A3A44B375723Q28078542-560DED90-242A-4330-922E-16AD45A705D0Q28079776-80406C65-1CEC-4422-9A76-E15D328126DE
P921
description
neoplasm (disease) that involves the uterine cervix
@en
name
livmorhalssvulst
@nn
tumeur du col utérin
@fr
uterine cervix neoplasm
@en
type
label
livmorhalssvulst
@nn
tumeur du col utérin
@fr
uterine cervix neoplasm
@en
altLabel
Cervical Tumor
@en
Cervix Neoplasm
@en
Cervix Tumor
@en
Cervix Uteri Neoplasm
@en
Cervix Uteri Tumor
@en
Neoplasm of Cervix Uteri
@en
Neoplasm of Cervix
@en
Neoplasm of the Cervix Uteri
@en
Neoplasm of the Cervix
@en
Neoplasm of the Uterine Cervix
@en
prefLabel
livmorhalssvulst
@nn
tumeur du col utérin
@fr
uterine cervix neoplasm
@en
P279
P672
P486
P1748
P2892
P31
P486
P5270
MONDO:0021230
P672
C04.588.945.418.948.850
C13.351.500.852.593.131
C13.351.500.852.762.850
C13.351.937.418.875.850